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Store-operated Ca 2+ entry (SOCE) and Ca 2+ release-activated Ca 2+ currents (I crac ) are strongly suppressed during cell division, the only known physiological situation in which Ca 2+ store depletion is uncoupled from the activation of Ca 2+ influx. We found that the endoplasmic reticulum (ER) Ca 2+ sensor STIM1 failed to rearrange into near-plasma membrane puncta in mitotic cells, a critical step in the SOCE-activation pathway. We also found that STIM1 from mitotic cells is recognized by the phospho-specific MPM-2 antibody, suggesting that STIM1 is phosphorylated during mitosis. Removal of ten MPM-2 recognition sites by truncation at amino acid 482 abolished MPM-2 recognition of mitotic STIM1, and significantly rescued STIM1 rearrangement and SOCE response in mitosis. We identified Ser 486 and Ser 668 as mitosis-specific phosphorylation sites, and STIM1 containing mutations of these sites to alanine also significantly rescued mitotic SOCE. Therefore, phosphorylation of STIM1 at Ser 486 and Ser 668, and possibly other sites, underlies suppression of SOCE during mitosis.
Cells use Ca
2+ as an important second messenger in the regulation of many processes, including exocytosis, immune cell activation and cell division 1 . There are two main sources of Ca 2+ : the extracellular medium and intracellular Ca 2+ storage organelles, most notably the ER. Ultimately, the ER must use extracellular Ca 2+ to maintain stored Ca 2+ levels through SOCE 2, 3 . This process is not only important for maintaining the ability of the ER to support subsequent Ca 2+ release events, but is also an important signalling mechanism, and it is becoming increasingly clear that certain processes are activated exclusively by Ca 2+ that enters the cell through the SOCE pathway 4, 5 .
The most ubiquitous and well-defined SOCE pathway involves I crac (refs 3, 6) . Two families of proteins are required for I crac activation: STIM (STIM1 and STIM2; refs 7, 8) Ca 2+ sensor proteins and Orai (Orai1, 2 and 3; refs 9-11) Ca 2+ channel subunits. Upon Ca 2+ store depletion, STIM1 relocalizes into punctate structures within the ER near the plasma membrane. 8, 12, 13 This dramatic rearrangement of STIM1 brings it into close apposition to the plasma membrane where it interacts with and activates Orai SOCE channels 14, 15 . By definition, SOCE is regulated primarily by ER Ca 2+ store levels. However, whether this process is modified by other signalling processes is not clear. The only known physiological situation in which SOCE seems to be strongly negatively regulated is during cell division [16] [17] [18] [19] 37 . However, the mechanism by which this suppression occurs is unknown. Here, we demonstrate that phosphorylation of STIM1 specifically during mitosis suppresses SOCE during cell division. These findings represent the first demonstration of a specific role for STIM1 phosphorylation, with significant implications for the process of SOCE activation. They also contribute to our understanding of the role of Ca 2+ signalling during cell division, a topic that has long been a source of mystery in cell biology [20] [21] [22] . In interphase HeLa cells, treatment with the sarco/ER ATPase inhibitor thapsigargin resulted in a sustained rise in cytoplasmic Ca 2+ , indicative of SOCE (Fig. 1a) . In the absence of extracellular Ca 2+ , sustained Ca 2+ elevation was lost, confirming that this sustained phase was due to Ca 2+ influx. To synchronize cells in mitosis, HeLa cells were treated with nocodazole (1.67 μM) for 16 h (ref. 23) after which approximately 50% of cells appeared mitotic on the basis of spherical morphology. As reported previously 16, 18 , mitotic HeLa cells showed no sustained Ca 2+ elevation, whereas flat interphase cells on the same coverslip showed normal sustained Ca 2+ elevation. Nocodazole-arrested mitotic HEK293 cells were treated with thapsigargin in the absence of extracellular Ca 2+ , to deplete Ca 2+ stores, and then had extracellular Ca 2+ restored to reveal SOCE. Restoration of extracellular Ca 2+ resulted in a large increase in cytoplasmic Ca 2+ in interphase cells, indicative of SOCE; this response was again absent in the nocodazole-treated mitotic cells or in round mitotic cells identified in non-nocodazole-treated asynchronous populations (Fig. 1b, c) .
STIM1 expression was not altered in mitotic HeLa or HEK293 cell lysates (Fig. 1d) . However, there was a striking increase in the apparent molecular weight of mitotic STIM1, probably due to STIM1 phosphorylation. In contrast, expression of Orai1 was reduced in mitotic cells by approximately 25-50%. However, the loss of SOCE in mitosis could not solely be due to a decrease in Orai1. First, Orai1 short interfering RNA (siRNA) in asynchronous cells decreased protein levels to a greater extent than the decrease in mitotic cells (Fig. 1d) , but inhibited Ca 2+ entry to a lesser extent (Fig. 1e) . Second, transfection of STIM1 and Orai1 greatly increased Orai1 expression in mitotic cells and produced large increases in SOCE in interphase cells, but did not rescue SOCE in mitotic cells ( Fig. 1f-h; Supplementary Information, Fig. 2a) .
STIM1 localization and function depend on microtubules 24, 25 . Thus, remodelling of the microtubule cytoskeleton into the mitotic spindle during mitosis may contribute to SOCE suppression 26 . In contrast to interphase HeLa cells, in which extensive colocalization of enhanced yellow fluorescent protein (eYFP)-STIM1 with α-tubulin was observed, eYFP-STIM1 localization was completely dissociated from that of α-tubulin in mitotic HeLa cells (Fig. 2a) . Additionally, there was a complete lack of eYFP-STIM1 rearrangement into puncta in response to Ca 2+ store depletion in mitotic HEK293 (Fig. 2b, c) and HeLa ( Supplementary  Information, Fig. 3 ) cells. This lack of STIM1 rearrangement can readily account for the failure of SOCE during mitosis. However, because the dissociation of STIM1 from microtubules does not prevent STIM1 puncta formation 25 , mechanisms other than microtubule dissociation must contribute to SOCE inhibition. The increase in apparent size of STIM1 during mitosis suggests phosphorylation 27, 28 . Thus, we immunoprecipitated STIM1 from asynchronous or nocodazole-arrested mitotic HeLa cells and probed precipitates with an anti-MPM-2 antibody, which recognizes phosphorylated serine or threonine that followed by proline [29] [30] [31] . Endogenous STIM1 or expressed eYFP-STIM1 from mitotic HeLa cells was recognized by MPM-2; proteins from asynchronous cells were not. The blots were reprobed for STIM1 or eYFP-STIM1, which revealed a band shift of mitotic STIM1 (Fig. 3a, b) . Identical results were also obtained with eYFP-STIM1 from mitotic HeLa cells isolated from asynchronous populations not treated with nocodazole ( Supplementary Information, Fig. 4a ). Thus, STIM1 is phosphorylated during mitosis at one or more MPM-2 recognition sites. eYFP-STIM2 was also recognized by MPM-2 in mitotic, but not asynchronous, immunoprecipitates ( Supplementary Information, Fig. 4c ).
Human STIM1 contains ten serines or threonines followed by prolines (the minimal recognition sequence for MPM-2) all within the cytoplasmic carboxyl-terminal region ( Supplementary Information,  Fig. 5 ). Given the large number of possible phosphorylation sites and the likelihood that several sites contribute to SOCE suppression, we initially used a truncation approach to examine the role of this C-terminal region. Truncation of eYFP-STIM1 at amino acid 482 (482STOP) resulted in a protein that was not recognized by MPM-2 (Fig. 3b) . Confocal imaging revealed that upon Ca 2+ store depletion, in interphase cells, 482STOP formed near-plasma membrane puncta that co-localized with cyan fluorescent protein (CFP)-Orai1, in a rearrangement indistinguishable from that of full-length eYFP-STIM1 (Fig. 3c) . In mitotic cells, the localization of full-length eYFP-STIM1 was unaltered after Ca 2+ store depletion, whereas there was substantial and near-complete rearrangement of 482STOP at the plasma membrane upon Ca 2+ store depletion (Fig. 3d) . This rearranged 482STOP co-localized with CFP-Orai1. Therefore, truncation of eYFP-STIM1 and subsequent loss of phosphorylation sites resulted in rearrangement into puncta, in mitotic cells, consistent with the hypothesis that STIM1 phosphorylation underlies the prevention of STIM1 rearrangement.
In interphase cells, 482STOP + Orai1 expression resulted in SOCE responses that were indistinguishable from those with full-length eYFP-STIM1 + Orai1 expression (Fig. 4a, b) , indicating that 482STOP supports SOCE activity despite the large truncation. Importantly, mitotic HEK293 cells expressing 482STOP + Orai1 showed SOCE that was substantially greater than that from mitotic eYFP-STIM1 + Orai1 cells ( Fig. 4a, b ; Supplementary Information, Fig. 2b ).
HEK293 cells co-expressing eYFP-STIM1 + Orai1 showed inward Ca 2+ currents at -100 mV of -10 to -20 pA/pF (Fig. 4c , e). These currents were inwardly rectifying with reversal potentials greater than +50 mV, and switching to a divalent-free (DVF) external solution resulted in an inwardly rectifying Na + conductance that was approximately five times greater than the Ca 2+ conductance (Fig. 4c, f) , all well-documented properties of I crac . Ca 2+ and Na + conductances were completely absent in 9 out of 11 mitotic eYFP-STIM1 + Orai1 cells (Fig. 4c , e, f). Ca 2+ -current densities in interphase 482STOP + Orai1 cells were smaller than those in eYFP-STIM1 and Orai1 cells (Fig. 4c, e ). Analysis of current-voltage relationships from interphase 482STOP + Orai1 cells revealed that Ca 2+ conductances were reduced at negative potentials, but Na + conductances were unaffected, suggesting an unknown effect on a Ca 2+ -dependent property of Orai1 channels due to the STIM1 truncation. Nonetheless, 7 out of 14 mitotic 482STOP + Orai1 cells showed Ca 2+ currents of 1 pA/ pF or greater (Fig. 4d, e) , and 12 out of 14 cells showed clear inwardly rectifying Na + currents (Fig. 4d, f) . The average Ca 2+ and Na + current densities in mitotic 482STOP + Orai1 cells were not significantly different from those in interphase cells (Fig. 4e, f) To identify individual phosphorylation sites of STIM1, eYFP-STIM1 immunoprecipitated from asynchronous or mitotic HEK293 cell lysates was subjected to mass spectrometry analysis (Supplementary Information, Table S1 ). Phosphorylated Ser 668 was identified in the mitotic, but not asynchronous, sample, suggesting mitosis-specific phosphorylation of Ser 668. Phospho-Ser 492 and phospho-Ser 553 were also identified in the mitotic sample, but unfortunately peptides containing these residues were not recovered from the asynchronous sample. Some sites were constitutively phosphorylated (Ser 575, Ser 620 and Ser 621), whereas others became dephosphorylated during mitosis (Ser 602 and Ser 608). Thus, STIM1 phosphorylation in mitosis is complex, involving both phosphorylation and dephosphorylation, as well as constitutive phosphorylation. Mass spectrometry analysis showed Ser 668 to be the strongest candidate for mitosis-specific phosphorylation. Additionally, we found that an anti-STIM1 antibody that recognizes amino acids 654-677 detected STIM1 in asynchronous, but not mitotic, samples. However, eYFP-STIM1 with Ser 668 mutated to alanine (S668A) was recognized from mitotic lysates as effectively as eYFP-STIM1 from asynchronous lysates (Fig. 5a ), suggesting that phosphorylation at Ser 668 significantly reduces the affinity of this antibody for STIM1. Ser 668 resides within a consensus sequence for phosphorylation by Cdk1 (cyclindependent kinase 1), which consists of Ser/Thr-Pro-X-Arg/Lys. Using the anti-STIM1 antibody to detect phosphorylation of Ser 668, we found that both endogenous STIM1 and eYFP-STIM1 are directly phosphorylated by Cdk1 at Ser 668 in vitro (Fig. 5b) .
S668A was still recognized by MPM-2 (data not shown), indicating the presence of additional phosphorylation sites. Ser 492 was also a potential MPM-2 site that was identified by mass spectrometry; however, the mass spectrometry data were ambiguous as to whether Ser 492 is phosphorylated specifically during mitosis. Thus, we truncated eYFP-STIM1 at amino acid 570 (570STOP), to form a protein that retained potential MPM-2 sites only at Ser 486 and Ser 492. 570STOP failed to support cells co-expressing eYFP-STIM1 and Orai1 (black) or 482STOP and Orai1 (blue). The whole-cell condition was achieved in the presence of external Ca 2+ (2.0 mM), followed by a switch to a divalent-free (DVF) external solution after 60 s. External Ca 2+ was restored at 120 s, and Gd 3+ (5 μM) was added at 180 s to demonstrate full inhibition of I crac currents. Current densities measured at -100 and +100 mV are plotted, and each trace represents the response of a single cell. Current-voltage relationships for the Ca 2+ currents just before the switch to DVF and for the peak DVF currents are shown on the right. (e, f) Peak leaksubtracted Ca 2+ (e) and Na + (f) currents, measured at -100 mV for each cell, were averaged and plotted. Interphase (Int) eYFP-STIM1 + Orai1, n = 9 cells; interphase 482STOP + Orai1, n = 13 cells; mitotic (Mit) eYFP-STIM1 + Orai1, n = 11 cells; mitotic 482STOP + Orai1, n = 14 cells. Asterisks indicate statistically significant difference (Student's t-test, P < 0.0001). Error bars represent mean ± s.e.m. S1 + O1, eYFP-STIM1 + Orai1. 482STOP + O1, 482STOP + Orai1. R(340/380), 340/380 fluorescence ratio.
SOCE or to show membrane-associated puncta formation in mitotic cells (data not shown). 570STOP immunoprecipitated from mitotic HeLa cells was recognized by MPM-2, but this was significantly reduced compared with recognition of mitotic eYFP-STIM1 (Fig. 5c) , whereas recognition of 570STOP S492A was unaffected (Fig. 5c) . Thus, phosphorylation of Ser 486 but not Ser 492 contributes to MPM-2 recognition of mitotic eYFP-STIM1. The reasons why this site was not identified by mass spectrometry and Ser 492 was phosphorylated specifically in mitosis but not recognized by MPM-2 are unclear. (2.0 mM), or a divalent-free (DVF) external solution. Gd 3+ (5 μM) was added at 180 s. Top, current densities at -100 and +100 mV are plotted, and each trace represents the response of one cell. Bottom, data represent mean ± s.e.m. peak leak-subtracted Ca 2+ and Na + currents (including nonresponding cells). Mitotic eYFP-STIM1 + Orai1, 12 cells; mitotic S486A/ S668A + Orai1, 13 cells. R(340/380), 340/380 fluorescence ratio.
We next tested the roles of the two identified sites in the suppression of SOCE. Constructs carrying either single site mutation (S668A or S486A) failed to significantly rescue SOCE in mitotic cells when co-expressed with Orai1 (Fig. 5e) . However, mitotic cells co-expressing Orai1 and eYFP-STIM1 with both Ser 486 and Ser 668 mutated to alanine (S486A/ S668A) showed SOCE responses significantly greater than mitotic eYFP-STIM1 + Orai1 cells (Fig. 5e) . Puncta formation of STIM1 S486A/S668A in mitotic cells was also more extensive than that of eYFP-STIM1 ( Fig. 5d;  Supplementary Information, Fig. 6 ). Six out of 13 mitotic STIM1 S486A/S668A + Orai1 cells showed I crac of 1 pA/pF or greater, compared with only 2 out of 12 mitotic eYFP-STIM1 + Orai1 cells (Fig. 5f ). These data collectively suggest that phosphorylation of both Ser 486 and Ser 668 contributes to SOCE suppression in mitosis. We also mutated Ser 486 and Ser 668 to potential phosphorylation-mimicking aspartic acids (S486D/S668D); however, SOCE responses and puncta formation were unaffected when co-expressed with Orai1 (data not shown). It is therefore possible that although phosphorylation of these sites clearly contributes to inhibition of SOCE, it may not be sufficient for full suppression. However, aspartic acids do not always mimic phosphorylation. The rescue of SOCE by STIM1 S486A/ S668A was not as great as that by 482STOP, further suggesting that other phosphorylation sites contribute. Because mass spectrometry indicated that Ser 602 and Ser 608 are phosphorylated during interphase but dephosphorylated in mitosis, we considered whether dephosphorylation of these sites may be involved. However, mutation of these sites to alanine failed to suppress SOCE in interphase cells (data not shown). In conclusion, our data clearly indicate a role of Ser 486 and Ser 668 phosphorylation in the suppression of SOCE during mitosis, but other determinants, including additional phosphorylation sites, are probably involved.
The mechanism by which STIM1 phosphorylation prevents store depletion-induced rearrangement into near-plasma membrane puncta is not clear. The fact that the large truncation of 482STOP supports SOCE, albeit less efficiently, suggests that the far C terminus of STIM1 may not be involved in direct activation of Orai, but rather serves as a regulatory region that modulates STIM1 function depending on its state of phosphorylation. This is consistent with recent publications documenting a specific Orai-interacting domain upstream of amino acid 482 (refs 32-35) . Regulation might result from the addition of negative charges preventing oligomerization due to electrostatic repulsion. STIM1 oligomerization precedes the movement of STIM1 toward the plasma membrane upon Ca 2+ store depletion 36 , and therefore prevention of oligomerization could underlie the lack of STIM1 rearrangement. Phosphorylation may also interfere with the interaction of STIM1 with unknown determinants that target STIM1 to near-plasma membrane punctae. Intriguingly, Ser 668 is near the poly-L-lysine region of STIM1, which has been suggested to interact with plasma membrane phospholipids 36 . It is also possible that STIM1 phosphorylation may contribute to functions other than SOCE suppression. For example, phosphorylation of STIM1 may underlie dissociation of STIM1 from microtubules during mitosis. Despite the fact that dissociation of STIM1 from microtubules does not seem to be essential for SOCE regulation, it may be necessary to prevent STIM1 from interfering with mitotic spindle function. STIM1 interacts with the microtubule-binding protein EB-1, and this interaction has been mapped to a region of STIM1 between amino acids 392 and 652 (ref. 24) , which includes several STIM1 phosphorylation sites. Therefore, it is possible that phosphorylation regulates the interaction of STIM1 with EB-1, preventing STIM1 localization to the mitotic spindle.
An important issue is the physiological reason for phosphorylation of STIM1 during mitosis. Although it seems most likely that suppression of SOCE is important, this is not necessarily the only reason. It is also possible that STIM1 is phosphorylated to carry out a new function during mitosis, and loss of its ability to activate Orai may be a secondary consequence. If this were the case, then phosphorylation of STIM2 might partially fulfil this function. This may explain why mutations that partially rescued SOCE during mitosis did not prevent cell division. It is also possible that phosphorylation of specific sites prevents their interaction with other cellular components, and deletion or mutation of these sites might accomplish the same thing, again resulting in a protein that is not detrimental to mitosis.
Despite these considerations, we carried out a quantitative analysis of the growth rate of HEK293 cells expressing 482STOP. However, the analysis was complicated by the fact that overexpression of full-length STIM1 + Orai1 significantly slowed growth; the reason for this effect is not clear, but probably relates to largely exaggerated SOCE responses. Despite this, the number of eYFP-STIM1 + CFP-Orai1 cells after three days of growth had increased 1.79 ± 0.12-fold, but this value was only 1.25 ± 0.13 for 482STOP + CFP-Orai1 cells (P = 0.004; paired Student's t-test; n = 7), suggesting a slower proliferation rate of 482STOP + CFP-Orai1 cells. Cellcycle analysis revealed that on the third day of growth, 3.02 ± 1.13% of the population of eYFP-STIM1 + CFP-Orai1 cells were at G2/M stage compared with 7.07 ± 0.85% of 482STOP + CFP-Orai1 cells (P = 0.04; paired Student's t-test; n = 3). This increase in the proportion of 482STOP cells at G2/M phase is consistent with a delay in mitosis, possibly due to a failure to fully suppress SOCE. Although these changes are relatively small, it should be noted that cells in culture may only infrequently encounter store-depleting stimuli during mitosis. In contrast, cells in physiological environments are continuously inundated with potential store-depleting agonists, and suppression of SOCE during mitosis may be an adaptive response that insulates mitotic cells from harmful Ca 2+ influx. 
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/. 
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METHODS
Reagents and plasmids. Nocodazole was from Calbiochem, and thapsigargin was from Alexis Biochemicals. STIM1 antibodies were from ProSci (C terminus; Product 4119) and Sigma (N terminus; Product S6072). The Orai1 antibody was from Sigma. The eYFP, α-tubulin and β-actin antibodies were from AbCam. The siRNA targeted to human Orai1 had the sequence 5ʹ-CCCUUCG-GCCUGAUCUUUAUCGUCU-3ʹ and the control siRNA was SiControl from Dharmacon. cDNAs encoding eYFP-tagged human STIM1 (eYFP-STIM1) and eYFP-tagged human STIM2 (eYFP-STIM2) were obtained from T. Meyer (Stanford University, CA, USA), and mutations of eYFP-STIM1 were generated using the QuikChange Site-Directed Mutagenesis kit (Stragagene). Untagged human Orai1 was from Origene and CFP-tagged human Orai1 was constructed as described previously 38 .
Cell culture and transfections. HEK293 and HeLa cells (both from ATCC) were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum and glutamine (2 mM) in a humidified CO 2 incubator at 37 °C. Transient cDNA transfections were carried out on cells plated to 90% confluency using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions, and transfected cells were used in experiments 48-72 h later. siRNA transfections were carried out similarly using the HiPerFect reagent (Stratagene), and transfected cells were used 48 h later.
Most immunoprecipitation analyses of STIM1 phosphorylation were carried out using HeLa cells because we found that non-mitotic HeLa cells remained well attached to the culture dish during collection of mitotic cells, allowing for collection of relatively pure mitotic samples. In contrast, it was more difficult to obtain mitotic HEK293 cell samples for biochemical analyses without significant contamination of non-mitotic cells. Most of our functional analyses used HEK293 cells, to take advantage of more efficient expression of co-transfected proteins.
Intracellular Ca
2+ measurements. Intracellular Ca 2+ measurements were carried out as described previously 39 . Briefly, cells were loaded with the Ca 2+ -sensitive dye fura-5F and were maintained in HEPES-buffered saline solution (HBSS; 120 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl 2 , 11 mM glucose and 20 mM HEPES, at pH 7.4) at room temperature throughout the course of the experiments. Fluorescence values at excitation wavelengths of 340 and 380 nm were measured consecutively at 6 s intervals for 20-30 individual cells on a single coverslip, using a microscopebased digital imaging system (Intracellular Imaging), and data representing relative intracellular Ca 2+ changes were plotted as 340/380 fluorescence ratios. Cells expressing eYFP-STIM1 or mutants thereof were selected at the beginning of the experiments on the basis of eYFP fluorescence when excited at 477 nm.
Confocal microscopy. Confocal microscopy was carried out using a Zeiss LSM 510 laser scanning system and a 63× oil-immersion lens (NA 1.4). For the mitotic image shown in Fig. 4a , a stack of 128 images was deconvolved using Huygens software, based on a theoretical point-spread function. For fixation, cells plated on LabTek chamber slides (Nalge Nunc) were rinsed in phosphate buffered saline (PBS; 137 mM NaCl, 2.68 mM KCl, 1.47 mM KH 2 PO 4 and 14.9 mM Na 2 HPO 4 , at pH 7.4), fixed for 1 min in 0.25% gluteraldehyde, lysed for 1 min in Karsenti's extraction buffer (80 mM Pipes, 1.0 mM MgSO 4 , 5.0 EGTA mM and 0.5% Triton X-100), post-fixed in gluteraldehyde for 10 min, and quenched in sodium borohybride (1 mg ml Electrophysiology. Whole-cell currents were measured in cells bathed in HBSS at room temperature using the patch-clamp technique. The intracellular pipette solution contained 145 mM cesium methanesulfonate, 20 mM BAPTA, 10 mM HEPES and 8 mM MgCl 2 (at pH 7.2 with CsOH). The pipette solution also contained 25 μM inositol 1,4,5-trisphosphate (InsPtd 3 ; Sigma) to rapidly deplete intracellular Ca 2+ stores upon break-in. Voltage ramps (+100 to -100 mV) of 250 ms were recorded every 2 s from a holding potential of 0 mV, and currents were acquired using pCLAMP 10 software (Axon Instruments). All currents were normalized on the basis of cell capacitance, and leak currents were taken immediately after break-in before I crac activation. Solutions were applied using a gravity-based multibarrel focal perfusion system (Perfusion Pencil, Automate Scientific).
Immunoprecipitation and western blotting. Cells were lysed in RIPA buffer (50 mM Tris HCl, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1% v/v NP-40 and 0.25% w/v sodium deoxycholate) supplemented with 1× Complete Mini Protease Inhibitor (Roche Applied Sciences) and 1× Halt Phosphatase Inhibitor Cocktail (Thermo Scientific). Protein concentrations were determined using the DC protein assay kit (BioRad). For immunoprecipitations, lysates containing equal protein amounts were pre-cleared for 1 h with Protein A/G beads (Thermo Scientific), incubated with primary antibodies overnight (anti-GFP, 1:500 dilution) and then incubated with Protein A/G beads for an additional 4 h, all at 4 °C. Beads were then washed three times with RIPA buffer, and proteins were eluted in Laemmli sample buffer containing 5% β-mercaptoethanol for 5 min at 95 °C. For western blotting, protein lysates diluted in Laemmli sample buffer containing 5% β-mercaptoethanol or eluates from immunoprecipitations were electrophoresed in 6% or 10% gels and transferred to PVDF membranes. All antibody dilutions and washes were carried out in Tris-buffered saline (TBS; 137 mM NaCl, 19 mM Tris HCl and 2.7 mM KCl, at pH 7.4) containing 0.1% Tween-20 (TBS-T). Membranes were blocked in 3% BSA in TBS-T for 1 h at room temperature, incubated with primary antibodies (anti-MPM-2, 1:2,000; anti-GFP, 1:50,000; anti-Orai1, 1:10,000; anti-STIM1 N terminus, 1:1,000; anti-STIM1 C terminus, 1:1,000) overnight at 4 °C, and incubated with secondary antibodies (horseradish peroxidase-linked anti-mouse or anti-rabbit; GE Healthcare) for 45 min at room temperature. Blots were developed with ECL Plus (GE Healthcare) and exposed to film. Stripping was carried out using Restore reagent (Thermo Scientific). For quantification of band intensities, films were scanned and analysed by densitometry using Photoshop software.
In vitro Cdk1 kinase assay. Crude membrane fractions were prepared by scraping HEK293 cells into hypotonic buffer (10 mM Tris-HCL, 10 mM NaCl, 1.5 mM MgCl 2 and 1 mM phenylmethylsulfonyl fluoride, at pH 7.5) containing 1× Complete EDTA-free Protease Inhibitor (Roche) followed by homogenization in a Dounce homogenizer. Intact cells and nuclei were removed by centrifugation at 1,000g for 5 min, and the supernatant was then centrifuged at 25,000g for 30 min. Membrane pellets were resuspended in Cdk1 kinase buffer (25 mM Tris-HCl, 10 mM MgCl2, 5 mM β-glycerophosphate, 0.1 mM Na 3 VO 4 , 2 mM dithiothreitol and 0.2 mM ATP, at pH 7.5) by sonication. Recombinant Cdk1/ cyclin B (Cell Signaling Technology) was added at a concentration of 200 ng per 100 μl reaction volume, and reactions were incubated at 37 °C overnight. Samples were then processed for western blotting.
Mass spectrometry. In-gel digestion with either trypsin or GluC, nanoLC-ESI-MS/MS, automated database searching, and manual spectral interpretation were performed essentially as described previously 40 . In addition to traditional collision induced dissociation, electron transfer dissociation (ETD) was also used for MS/ MS experiments. ETD settings included the use of fluoranthine as the electron donor with negative ion source settings that included a 150 eV ionization energy and a 100 ms accumulation time. To enrich phosphopeptides, metal oxide affinity chromatography was performed using TiO 2 tips (Glygen Corp.) according to the manufacturer's recommended protocol.
Proliferation rate and cell-cycle analysis. For analysis of proliferation rates, equal numbers of eYFP-STIM1 or 482STOP and CFP-Orai1 co-transfected cells were plated, and on each day for three days cells were trypsinized and counted using a hemocytometer. The same populations of cells were then analysed using a LSR II flow cytometer and FACSDiva software (BD Biosciences) to determine the proportion of CFP and eYFP double-positive cells. eYFP fluorescence was determined by excitation with a 488 nm laser and a 530/30 nm emission filter, and CFP by excitation with a 405 nm laser and a 525/50 nm emission filter. Gates for eYFP and CFP positive cells were established using untransfected cells. A total of 10,000 viable cells were analysed per sample, and the proportion of double-positive cells was multiplied by the total number of cells obtained by counting to determine the total number of double-positive cells per sample. The total number of double-positive cells on day 3 was divided by that on day 1 to obtain the proliferation rate. For cell-cycle analysis, trypsinized cells were fixed in 70% ethanol at 4 °C overnight, pelleted and re-suspended in propidium iodide (PI) solution (20 μg ml -1 PI and 10 U ml -1 Rnase in PBS) for 20 min. Cells were then analysed by flow cytometry to initially identify CFP-and YFP-positive cells as described, followed by cell-cycle analysis. DNA content was determined using PI fluorescence with excitation at 488 nm and 575/26 nm emission on a double discrimination dot plot based on PI area versus width (to exclude cell aggregates). Data were then modelled using Modfit LT software (Verity Software House) to obtain proportions of cells at specific cell-cycle stages. 
Table S1
Mass spectrometry analysis of STIM1 phosphorylation. eYFP-STIM1 was immunoprecipitated from asynchronous or mitotic HEK293 cell lysates and resolved by gel electrophoresis, and bands were excised and analyzed by mass spectrometry. 'N/C': no coverage, meaning that a peptide containing the particular amino acid was not recovered; '-': sequence was recovered but phosphorylation was not detected; '+': phosphorylation of the amino acid was detected. 
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